×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
NeuBase Therapeutics shareholder meeting fails to get enough votes for dissolution - Pittsburgh Business Times
The Business Journals
Listen to this article 2 min. CEO says company will continue to pursue dissolution. NeuBase Therapeutics Inc.'s second attempt to get...
13 hours ago
NeuBase Therapeutics plans dissolution as finances fall apart
Technical.ly
Once-promising Pittsburgh biotech firm shutting down for good · Just a year ago, NeuBase's CEO was optimistic, but its board has now determined...
1 month ago
Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?
InvestorPlace
Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today? · NeuBase Therapeutics (NBSE) stock is down on Tuesday after announcing a special...
1 month ago
NeuBase Therapeutics board approves plan to dissolve company
The Business Journals
NeuBase Therapeutics' board of directors voted Thursday to dissolve and liquidate the Pittsburgh-based biotech firm, according to a document...
3 months ago
Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical ...
WJTV
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better...
1 week ago
Small biotech ends stealth gene editing mission, seeks sale
Fierce Biotech
Gene editing biotech NeuBase Therapeutics is stopping program development and looking for a sale after its board of directors voted to close...
9 months ago
NeuBase Therapeutics Plans Dissolution and Asset Liquidation - TipRanks.com
Tipranks
NeuBase Therapeutics Inc (NBSE) has released an update. NeuBase Therapeutics, Inc. is set to dissolve, liquidate its assets, and distribute them to...
2 months ago
NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Sees Significant Decrease in Short Interest
Defense World
Read NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Sees Significant Decrease in Short Interest at Defense World.
2 weeks ago
Pittsburgh's NeuBase Therapeutics targets incurable disease with licensing agreement
Pittsburgh Post-Gazette
NeuBase Therapeutics Inc. is licensing its treatment for Huntington's disease to Helexva Inc., a startup with five part-time employees that...
9 months ago
Thinking about buying stock in iCoreConnect, Novo Integrated Sciences, Plus Therapeutics, Smith & Wesson Brands ...
FOX40
NEW YORK, Sept. 8, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ICCT, NVOS, PSTV, SWBI, and NBSE.
8 months ago